Copper drug Cu(ATSM) clears 42% of toxic Alzheimer’s proteins and improves memory in laboratory studies.
Copper drug Cu(ATSM) clears 42% of toxic Alzheimer’s proteins and improves memory in laboratory studies.
A copper-based compound has cut Alzheimer’s toxic protein accumulation by 42 percent in laboratory cell models, opening a potential new avenue for treating the disease.